Not applicableStudy completedNCT01881386What this trial is testingLactate Imaging as a Tumour BiomarkerWho this might be right forCancer Institute of Cancer Research, United Kingdom 37
Testing effectiveness (Phase 2)Looking for participantsNCT06927180What this trial is testingSHR-A1811 Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BCWho this might be right forBreast Cancer Early Stage Breast Cancer (Stage 1-3) Henan Cancer Hospital 180
Early research (Phase 1)Study completedNCT03129061What this trial is testingStudy to Evaluate Immunological Response to PD-1 Inhibition in Squamous Cell Carcinoma of the Head and Neck (SCCHN)Who this might be right forSquamous Cell Carcinoma of the Head and Neck CellSight Technologies, Inc. 15
Early research (Phase 1)Ended earlyNCT03619655What this trial is testingAssessment of Multi-Modality Quantitative Imaging for Evaluation of Response of Metastatic Prostate Cancer to TherapyWho this might be right forProstate Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3
Testing effectiveness (Phase 2)Looking for participantsNCT04865250What this trial is testingPredicting Response to Neoadjuvant ATEZOLIZUMAB Plus Carboplatin/Nab Paclitaxel in Resectable Non-squamous NSCLCWho this might be right forNSCLC Stage IINSCLC, Stage IIIANSCLC Stage IIIB University Hospital Heidelberg 20
Not applicableLooking for participantsNCT05184582What this trial is testingPhysical Exercise During Preoperative Chemotherapy for Breast CancerWho this might be right forBreast Cancer Karolinska Institutet 712
Not applicableNot Yet RecruitingNCT07410715What this trial is testingSurgery vs. Watch-and-Wait Strategy in Complete Responders for Hepatocellular Carcinoma (SWITCH)Who this might be right forHCC - Hepatocellular CarcinomaWatch & WaitSurgery West China Hospital 100
Not applicableUnknownNCT06041815What this trial is testingCorrelation Between Gut Microbiota and Clinical Response to CAR-T Treatment for Hematological MalignanciesWho this might be right forHematological MalignanciesChimeric Antigen Receptor T-cell Therapy The First Affiliated Hospital of Soochow University 100
Early research (Phase 1)Study completedNCT05177640What this trial is testingBiodistribution and Dosimetry of 99mTc-DuramycinWho this might be right forHealthy Volunteers University Hospital, Antwerp 6
Not applicableUnknownNCT05640024What this trial is testingProspective Cohort Study for Validation of Predictive Immune Biomarkers of Response to PAPR InhibitorsWho this might be right forOvarian Cancer Yonsei University 54
Testing effectiveness (Phase 2)Study completedNCT02307227What this trial is testingPhase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- TumorsWho this might be right forBreast Neoplasms Centro di Riferimento Oncologico - Aviano 46
Post-approval studies (Phase 4)Study completedNCT00090038What this trial is testingEffect of Rituximab on Immunological Recall Response to Specific Antigens in the Treatment of Non-Hodgkin's LymphomaWho this might be right forNon-Hodgkin's Lymphoma Biogen 168
Not applicableUnknownNCT01612247What this trial is testingLow Dose Chemotherapy With Aspirin in Patients With Breast Cancer After Neoadjuvant ChemotherapyWho this might be right forBreast Cancer University of Vermont 13
Post-approval studies (Phase 4)Ended earlyNCT05075538What this trial is testingCOVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2Who this might be right forCancer Jules Bordet Institute 152
Testing effectiveness (Phase 2)Ended earlyNCT00595985What this trial is testingSorafenib as a Second Line Treatment in Patients With Advanced or Metastatic Gastric CancerWho this might be right forGastric Cancer Fudan University 5
Large-scale testing (Phase 3)Study completedNCT03632135What this trial is testingStandard Chemotherapy vs. Chemotherapy Guided by Cancer Stem Cell Test in Recurrent GlioblastomaWho this might be right forRecurrent Glioblastoma Cordgenics, LLC 78
Large-scale testing (Phase 3)Looking for participantsNCT05929768What this trial is testingShorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerWho this might be right forAnatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8+2 more SWOG Cancer Research Network 2,400
Testing effectiveness (Phase 2)Ended earlyNCT04310397What this trial is testingDabrafenib, Trametinib, and Spartalizumab for the Treatment of BRAF V600E or V600K Mutation Positive Stage IIIB/C/D MelanomaWho this might be right forPathologic Stage IIIB Cutaneous Melanoma AJCC v8Pathologic Stage IIIC Cutaneous Melanoma AJCC v8Pathologic Stage IIID Cutaneous Melanoma AJCC v8 M.D. Anderson Cancer Center 4
Testing effectiveness (Phase 2)Study completedNCT00072059What this trial is testingRo 50-3821 in Treating Anemia in Patients Receiving Antineoplastic Therapy for Stage IIIB or Stage IV Non-Small Cell Lung CancerWho this might be right forAnemiaLung Cancer Jonsson Comprehensive Cancer Center
Not applicableEnded earlyNCT01954576What this trial is testingNovoTTF Therapy in Treating Patients With Recurrent Glioblastoma MultiformeWho this might be right forGlioblastomaBrain Neoplasms University of Florida 21